Shabir Madhi, who is leading the South African vaccine trial, said that Africa could have a COVID-19 vaccine in the first quarter of 2021 if a clinical trial in South Africa succeeds, as reported Fidelity on Thursday.
The ChAdOx1 nCoV-19 experimental vaccine is also being tested in Brazil by Oxford University scientists who is working with AstraZeneca.
"A vaccine could be made commercial as early as the beginning of next year," Madhi said, "but it is completely dependent on the results of clinical trials."
Madhi noted that early results could be seen by November or December.
"The timing of an efficacy read-out depends on when we have around 42 COVID-19 cases at least one month after vaccination," he said.
To read more NewsPoints articles, click here.